CHRU Jean Minjoz

Futó vizsgálatok

• Még nem toboroz

  Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer

  NCT07587827· 1. fázis· Forrás

• Még nem toboroz

  A phase 1, open-label, dose-escalation and dose-expansion study evaluating the safety, feasability and efficacy of ODI-2001 vaccine, a personalized immunotherapy, in patients with metastatic or locally advanced colon cancer of pancreatic cancer

  2025-523172-23-00· 1. fázis· Forrás

• Toboroz

  Withdrawal of Dupilumab in Severe Asthma

  NCT06818019· 4. fázis· Forrás

• Fut, nem toboroz

  Treatment of microstellite stable metastatic colorectal cancer presenting high immune infiltrate with chemotherapy (XELOX or FOLFOX Bevacizumab) and immunotherapy ( Pembrolizumab)

  NCT04262687· 2. fázis· Forrás

• Fut, nem toboroz

  Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.

  NCT04730544· 2. fázis· Forrás

• Toboroz

  Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

  NCT03651206· 2/3. fázis· Forrás

• Fut, nem toboroz

  LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy

  NCT04166604· 2. fázis· Forrás

• Fut, nem toboroz

  Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

  NCT03022188· Forrás

• Fut, nem toboroz

  Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma

  NCT00470223· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák3 toboroz
• Hasnyálmirigyrák2 toboroz
• Asztma1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Toboroz

  Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

  NCT05254171· 2/3. fázis· Forrás

• Lezárult

  Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation

  NCT04626466· Forrás

• Lezárult

  Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

  NCT03941093· 3. fázis· Forrás

• Lezárult

  UTOLA: UTerin OLAparib

  NCT03745950· 2. fázis· Forrás

• Lezárult

  PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .

  NCT03275506· 2. fázis· Forrás

• Lezárult

  ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

  NCT02891824· 3. fázis· Forrás